Connect with us

Hi, what are you looking for?

press release

Medical implants could one day be made out of CBD or poly – Press Release

robina weermeijer z8 fmfz06c unsplash

CBD could one day be used in medical implants after a new study published in a peer-reviewed scientific journal American Chemical Society, reported phys.org.

Polycannabinoids: CBD-based bioplastics

The bioplastic called poly(lactic acid) or PLA has become a popular sustainable plastic option because it is made from corn and sugarcane instead of fossil fuels. CBD, the non-psychotropic component of cannabis and hemp, has a chemical structure that results in a “good building block” for PLA, which could replace traditional plastics for medical use.

researcher Gregory Sotzing, Lakshmi Nair and Colleagues performed a condensation reaction using adipoyl chloride — also used to make nylon — and either CBD or the closely related cannabigerol (CBG) to create a new bioplastic. They also examined the properties of the polymers.

“Neither CBD nor CBG polyesters were cytotoxic. Unlike the traditional bioplastic PLA, the CBD polyester had antioxidant activity,” the study said. “Polymeric CBD had a wide melting temperature range and extensibility. To demonstrate its ability to function as a plastic, the researchers molded it into a hemp leaf shape using a mold.”

Sotzing said the future goal of his start-up Polycannabinoid Therapeutics Rx is to develop anti-inflammatory and pain-relieving bioplastics.

Photo of Robina Weermeier on Unsplash.

Source Story here

You May Also Like

Business

State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...